Publikační okénko
 |
Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track? Zuna J, Hovorkova L, Krotka J, Winkowska L, Novak Z, Sramkova L, Stary J, Trka J, Cazzaniga G, Cario G, Zaliova M. Am J Hematol. 2023 Jul 14. |
 |
Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. Alquezar-Artieda N, Kuzilkova D, Roberts J, Hlozkova K, Pecinova A, Pecina P, Zwyrtkova M, Potuckova E, Kavan D, Hermanova I, Zaliova M, Novak P, Mracek T, Sramkova L, Tennant DA, Trka J, Starkova J. Blood Adv. 2022 Nov 18:bloodadvances.2021006431. |
 |
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol. Svaton M, Skotnicova A, Reznickova L, Rennerova A, Valova T, Kotrova M, van der Velden VHJ, Brüggemann M, Darzentas N, Langerak AW, Zuna J, Stary J, Trka J, Fronkova E. Blood. 2022 Oct 14. |